title: Reversible bone marrow reticulin fibrosis as a side effect of romiplostim therapy for the treatment of chronic refractory immune thrombocytopenia.
authors.forename: Teresa
authors.initials: T
authors.lastname: Leung
authors.forename: Julie
authors.initials: J
authors.lastname: Lokan
authors.forename: Paul
authors.initials: P
authors.lastname: Turner
authors.forename: Carole
authors.initials: C
authors.lastname: Smith
mesh_terms: D000368:Aged; D001853:Bone Marrow / Q000473:pathology*; D004351:Drug Resistance; D005355:Fibrosis / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy / Q000473:pathology*; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin / Q000037:antagonists & inhibitors*; D011993:Recombinant Fusion Proteins / Q000009:adverse effects*; D020127:Recovery of Function; D012155:Reticulin; D013926:Thrombopoietin / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D012155:Reticulin; D013926:Thrombopoietin; C488777:romiplostim